120 related articles for article (PubMed ID: 19782443)
1. Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis.
Patel BP; Hamadeh MJ
Clin Nutr; 2009 Dec; 28(6):604-17. PubMed ID: 19782443
[TBL] [Abstract][Full Text] [Related]
2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
3. Nutritional advice and treatment by dietitians to patients with amyotrophic lateral sclerosis/motor neurone disease: a survey of current practice in England, Wales, Northern Ireland and Canada.
Rio A; Cawadias E
J Hum Nutr Diet; 2007 Feb; 20(1):3-13. PubMed ID: 17241187
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death in amyotrophic lateral sclerosis: a mechanism of pathogenic and therapeutic importance.
Przedborski S
Neurologist; 2004 Jan; 10(1):1-7. PubMed ID: 14720310
[TBL] [Abstract][Full Text] [Related]
5. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients.
Genton L; Viatte V; Janssens JP; Héritier AC; Pichard C
Clin Nutr; 2011 Oct; 30(5):553-9. PubMed ID: 21798636
[TBL] [Abstract][Full Text] [Related]
6. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
7. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
8. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
de Carvalho M; Swash M
Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
[TBL] [Abstract][Full Text] [Related]
9. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis.
Kirkinezos IG; Hernandez D; Bradley WG; Moraes CT
Ann Neurol; 2003 Jun; 53(6):804-7. PubMed ID: 12783429
[TBL] [Abstract][Full Text] [Related]
10. Motor cortex stimulation for amyotrophic lateral sclerosis. Time for a therapeutic trial?
Di Lazzaro V; Oliviero A; Saturno E; Pilato F; Dileone M; Sabatelli M; Tonali PA
Clin Neurophysiol; 2004 Jun; 115(6):1479-85. PubMed ID: 15134719
[TBL] [Abstract][Full Text] [Related]
11. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
Morrison BM; Morrison JH; Gordon JW
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic mechanisms in amyotrophic lateral sclerosis.
Sandyk R
Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
[TBL] [Abstract][Full Text] [Related]
14. Experimental models of amyotrophic lateral sclerosis.
Elliott JL
Neurobiol Dis; 1999 Oct; 6(5):310-20. PubMed ID: 10527800
[TBL] [Abstract][Full Text] [Related]
15. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
Heath PR; Shaw PJ
Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
[TBL] [Abstract][Full Text] [Related]
16. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
Mitchell JD
J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
[TBL] [Abstract][Full Text] [Related]
18. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis.
Muscaritoli M; Kushta I; Molfino A; Inghilleri M; Sabatelli M; Rossi Fanelli F
Nutrition; 2012 Oct; 28(10):959-66. PubMed ID: 22677356
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis--the tools of the trait.
Lederer CW; Santama N
Biotechnol J; 2007 May; 2(5):608-21. PubMed ID: 17345579
[TBL] [Abstract][Full Text] [Related]
20. Protein biomarkers for amyotrophic lateral sclerosis.
Ryberg H; Bowser R
Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
